Aya Michaels MD, Presenter: Nothing to Disclose

Catherine Streeto Giess MD, Abstract Co-Author: Nothing to Disclose

Chris Sungwon Chung MD, Abstract Co-Author: Nothing to Disclose

Elisabeth P. Frost MD, Abstract Co-Author: Nothing to Disclose

Robyn L. Birdwell MD, Abstract Co-Author: Nothing to Disclose

1. To review mammographic criteria for probably benign (BIRADS 3) lesions according to the BIRADS lexicon 2. To discuss the complementary but occasionally conflicting roles of mammographic change versus morphology in assessing and managing BIRADS 3 lesions 3. To illustrate challenging clinical situations affecting assessment and management, including lesion location, lack of prior studies, US correlation, and effect of technology on assessment of stability 4. To present a pictorial review of upgraded BIRADS 3 lesions, benign and malignant, with assessment and management lessons

1. A brief overview of the mammographic criteria for a probably benign (BIRADS 3) lesion on mammography 2. Discuss the balance between imaging morphology and demonstrable imaging change or increased lesion conspicuity 3. Illustrate the role and limitations of diagnostic US in evaluation of mammographic BIRADS 3 lesions 4. Illustrate benign and malignant cases upgraded from probably benign to suspicious during imaging follow-up that demonstrate important teaching points  

http://abstract.rsna.org/uploads/2014/14011908/14011908_blmd.pdf

Michaels, A, Giess, C, Chung, C, Frost, E, Birdwell, R, Mammographic BIRADS 3 Lesions Upgraded During Imaging Surveillance: Common Errors in Initial/Subsequent Assessment and How to Avoid Them.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011908.html